From precision diagnostics to personalized treatment and long-term recovery management, frontier technology creates a seamlessly connected precision prevention and care pathway.
Integrates physical examination reports, physiological indicators, health history, lifestyle, genetics, and multi-omics data to identify chronic disease, metabolic, inflammatory, and aging-related risks and turn fragmented information into a continuously trackable personal health profile.
Builds an explainable, updateable personal baseline from multiple health data sources to support risk identification and long-term health management.
Integrated Health Data
Priority Risk Domains
Structures and consolidates examination, physiological, medical-history, lifestyle, and multi-omics data to reduce information silos.
Analyzes relationships among key indicators to surface potential risks, abnormal trends, and health concerns that warrant ongoing attention.
Generates nutrition, food-as-medicine, dietary supplement, exercise, and lifestyle recommendations based on individual status.
Tracks key indicators and follow-through over time to evaluate trends and refine long-term health management plans.
For health management reference only; not a substitute for professional diagnosis.
By understanding drug structures and mechanisms, GenoMind precisely matches effective anticancer strategies and helps clinicians deliver internationally advanced personalized care.
By understanding drug structures and mechanisms, GenoMind precisely matches effective anticancer strategies and helps clinicians deliver internationally advanced personalized care.
OncoKB, CIVIC, ClinVar, and other databases, combined with Chinese and international guidelines and expert consensus
High-sensitivity NGS testing, synchronized imaging and pathology interpretation, and precise patient-record analysis
High-grade evidence, traceable logic, and transparent decisions
Identifies each patient's physical status and prioritizes treatment pathways
Tracks emerging therapies and precisely matches the most effective options to mutation signals.
Prioritizes guideline-supported options, favoring reimbursed therapies and lower-cost established drugs.
MRD surveillance can flag recurrence six months earlier and target emerging resistant disease.
Traditional formulas and botanical extracts form a low-toxicity recovery matrix that improves the tumor microenvironment.
Multi-omics testing and AI decode each person's aging profile to build targeted interventions from cellular repair to system-wide functional optimization, improving cellular vitality, metabolic health, and quality of life beyond surface-level change.
Genomic, epigenomic, proteomic, and other multidimensional data power a proprietary dynamic aging score, translating each person's aging-factor map into a tailored intervention pathway.
Developed with clinical resources, the three-tier system combines proactive defense, precision repair, and clinical-grade reinforcement to improve outward vitality and internal function together.
AI foundation models connect mechanisms across diseases and reveal new drug actions, generating innovative options for people with refractory disease or no established therapy. One person, one strategy, renewed hope.
AI foundation models connect mechanisms across diseases, uncover new drug actions, simulate drug-target binding, and predict whether established drugs may work against rare mutations.
Quantifies the balance between drug toxicity and tumor suppression, then generates dose-adjustment formulas for individualized precision treatment.
Every recommendation carries a traceable evidence chain and transparent reasoning process, giving clinicians a clear basis for each treatment decision.
Provides innovative repurposing options when no standard treatment exists.
Finds new treatment opportunities after standard options have been exhausted.
Includes high-evidence, lower-cost established drugs to reduce the financial burden of care.
AI foundation models interpret classical formulas, match them to patient genomic profiles, and combine them with dietary supplements to improve the tumor microenvironment through multi-target synergy and support a durable, low-toxicity strategy.
AI foundation models interpret classical formulas, match them to patient genomic profiles, and generate targeted traditional-medicine strategies that suppress tumors while improving the microenvironment for durable, low-toxicity care.
Centered on three-dimensional regulation across genes, microenvironment, and metabolism, AI precisely combines nutritional supplements and botanical extracts into medium- and long-term recovery plans.
Move beyond suppressing tumors alone by creating an internal environment that naturally resists them, combining the strengths of traditional wisdom and modern science.
